{
    "clinical_study": {
        "@rank": "124446", 
        "acronym": "Bakri", 
        "arm_group": [
            {
                "arm_group_label": "With Bakri balloon", 
                "arm_group_type": "Experimental", 
                "description": "Patients randomized to this arm will be treated using the Bakri balloon.\nIntervention: Bakri balloon"
            }, 
            {
                "arm_group_label": "Without Bakri balloon", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients randomized to this arm will receive routine care not including the Bakri Balloon.\nIntervention: Routine Care"
            }
        ], 
        "brief_summary": {
            "textblock": "This study concerns women diagnosed with postpartum hemorrhage and requiring sulprostone\n      therapy.  Included patients are randomized to two arms: the \"Sulprostone + Bakri balloon\"\n      arm versus the \"Sulprostone alone\" arm.\n\n      The main objective of this study is to compare the efficiency of a care strategy  including\n      the Bakri balloon to that of routine care without the Bakri balloon via a cost-consequence\n      study juxtaposing costs and the necessity of invasive procedures (arterial embolization,\n      ligation of arteries, hysterectomy, intrauterine sutures) for controlling postpartum\n      hemorrhage."
        }, 
        "brief_title": "Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Postpartum Hemorrhage", 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Postpartum Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient, her person-of-trust, must have given his/her consent and signed the\n             consent form / inclusion decision made by the investigator when a person-of-trust is\n             absent\n\n          -  The patient must be insured or beneficiary of a health insurance plan\n\n          -  The patient is able to fluently read and speak French\n\n          -  Blood loss > 500ml and sulprostone treatment is insufficient at 20 minutes\n\n          -  Duration of pregnancy > 32 weeks of amenorrhea\n\n          -  Uterine atony\n\n        Exclusion Criteria:\n\n          -  The patient is participating in another study\n\n          -  The patient is in an exclusion period determined by a previous study\n\n          -  The patient is under judicial protection, under tutorship or curatorship\n\n          -  The patient refuses to sign the consent\n\n          -  It is impossible to correctly inform the patient\n\n          -  The patient cannot read French\n\n          -  The patient was transferred to another center not among the centers participating in\n             this study\n\n          -  The patient has a contraindication for a treatment used in this study (Sulprostone),\n             or an incompatible treatment combination\n\n          -  The patient has a contraindication for third level  techniques\n\n          -  The patient has at least one of the following conditions: chorioamnionitis, cervical\n             cancer, uterine rupture, anatomical abnormality preventing the introduction of the\n             device, purulent infection of the vagina, cervix or uterus."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "66", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01980173", 
            "org_study_id": "LOCAL/2012/VL-04", 
            "secondary_id": "2013-A00914-41"
        }, 
        "intervention": [
            {
                "arm_group_label": "Without Bakri balloon", 
                "description": "Following diagnosis with post-partum hemorrhage, an initial 30 minute phase corresponding to current recommendations, an injection of sulprostone, a demonstrated inefficacy of sulprostone 20 minutes after the injection and finally randomization, patients in this arm of the study will continue to have routine care.", 
                "intervention_name": "Routine care", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "With Bakri balloon", 
                "description": "Following diagnosis with post-partum hemorrhage, an initial 30 minute phase corresponding to current recommendations, an injection of sulprostone, a demonstrated inefficacy of sulprostone 20 minutes after the injection and finally randomization, patients in this arm will be treated with the immediate placement of a Bakri balloon, followed by routine care if necessary.", 
                "intervention_name": "Bakri balloon", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Bakri balloon", 
        "lastchanged_date": "April 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Al\u00e8s", 
                        "country": "France", 
                        "zip": "30103"
                    }, 
                    "name": "CH d'Al\u00e8s"
                }, 
                "investigator": {
                    "last_name": "Khalil Bentahar, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Arles Cedex", 
                        "country": "France", 
                        "zip": "13637"
                    }, 
                    "name": "CH d'Arles - H\u00f4pital Joseph Imbert"
                }, 
                "investigator": {
                    "last_name": "Anne Margarot, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clamart Cedex", 
                        "country": "France", 
                        "zip": "92141"
                    }, 
                    "name": "APHP - H\u00f4pital Antoine Beclere"
                }, 
                "investigator": {
                    "last_name": "Alexandra Benachi, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Kremlin Bic\u00eatre Cedex", 
                        "country": "France", 
                        "zip": "94275"
                    }, 
                    "name": "APHP - Centre Hospitalier Universitaire de Bic\u00eatre"
                }, 
                "investigator": [
                    {
                        "last_name": "Herv\u00e9 Fernandez, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Marie Houllier, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille Cedex 20", 
                        "country": "France", 
                        "zip": "13915"
                    }, 
                    "name": "APHM - H\u00f4pital Nord"
                }, 
                "investigator": {
                    "last_name": "Florence Bretelle, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "CHRU de Montpellier - H\u00f4pital Arnaud de Villeneuve"
                }, 
                "investigator": [
                    {
                        "last_name": "Emmanuelle Vintejoux, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "M\u00e9lanie Cayrac, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "N\u00eemes Cedex 9", 
                        "country": "France", 
                        "zip": "30029"
                    }, 
                    "name": "CHRU de N\u00eemes - H\u00f4pital Universitaire Car\u00e9meau"
                }, 
                "investigator": [
                    {
                        "last_name": "Vincent Letouzey, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Eve Mousty, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Pierre Mar\u00e8s, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Florent Masia, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Renaud de Tayrac, MD, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint-Priest en Jarez", 
                        "country": "France", 
                        "zip": "42270"
                    }, 
                    "name": "CHU de Saint Etienne - H\u00f4pital Nord"
                }, 
                "investigator": {
                    "last_name": "C\u00e9line Chauleur, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care", 
        "overall_contact": {
            "email": "vincent.letouzey@chu-nimes.fr", 
            "last_name": "Vincent Letouzey, MD", 
            "phone": "+33.(0)4.66.68.37.99"
        }, 
        "overall_contact_backup": {
            "email": "carey.suehs@chu-nimes.fr", 
            "last_name": "Carey Suehs, PhD", 
            "phone": "+33.(0)4.66.68.67.88"
        }, 
        "overall_official": {
            "affiliation": "Centre Hospitalier Universitaire de N\u00eemes", 
            "last_name": "Vincent Letouzey, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "The % of patients requiring invasive measures for postpartum hemorrhage control.", 
                "safety_issue": "Yes", 
                "time_frame": "Hospital stay (expected max of 15 days)."
            }, 
            {
                "measure": "The total cost (\u20ac) associated with the postpartum hemorrhage management strategy.", 
                "safety_issue": "No", 
                "time_frame": "Hospital stay (expected max of 15 days)."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01980173"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The delay required to stop bleeding post-delivery (min)", 
                "safety_issue": "Yes", 
                "time_frame": "post-partum (expected maximum of a few hours)"
            }, 
            {
                "measure": "The delay required to stop bleeding post-diagnosis (min)", 
                "safety_issue": "Yes", 
                "time_frame": "post-partum (expected maximum of a few hours)"
            }, 
            {
                "measure": "The percentage of patients still bleeding 30 minutes after sulprostone injection", 
                "safety_issue": "Yes", 
                "time_frame": "30 minutes after sulprostone injection (day 0)"
            }, 
            {
                "measure": "Blood loss (ml) 30 minutes after diagnosis", 
                "safety_issue": "Yes", 
                "time_frame": "30 minutes after diagnosis (day 0)"
            }, 
            {
                "measure": "Blood loss (ml) 1 hour after diagnosis", 
                "safety_issue": "Yes", 
                "time_frame": "1 hour after diagnosis (day 0)"
            }, 
            {
                "measure": "Blood loss (ml) 2 hours after diagnosis", 
                "safety_issue": "Yes", 
                "time_frame": "2 hours after diagnosis (day 0)"
            }, 
            {
                "measure": "Blood loss (ml) 24 hours after diagnosis", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours after diagnosis (day 1)"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "Upon diagnosis (day 0)"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "30 minutes after diagnosis (day 0)"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "120 minutes after diagnosis (day 0)"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours after diagnosis (day 1)"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "upon sulprostone injection (day 0)"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "when placing the Bakri balloon (day 0)"
            }, 
            {
                "measure": "Blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "when performing invasive techniques (expected day 0 or 1)"
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "Upon diagnosis (day 0)"
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "30 minutes after diagnosis (day 0)"
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "120 minutes after diagnosis (day 0)"
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours after diagnosis (day 1)"
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "upon sulprostone injection (day 0)"
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "when placing the Bakri balloon (day 0)"
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "when performing invasive techniques (expected day 0 or 1)"
            }, 
            {
                "measure": "The % of patients requiring blood transfusion.", 
                "safety_issue": "Yes", 
                "time_frame": "Hospital stay (expected max of 15 days)."
            }, 
            {
                "measure": "The % of patients requiring intravenous iron.", 
                "safety_issue": "Yes", 
                "time_frame": "Hospital stay (expected max of 15 days)."
            }, 
            {
                "measure": "The quantity of packed red cells, platelet concentrate and fresh frozen plasma consumed", 
                "safety_issue": "Yes", 
                "time_frame": "Hospital stay (expected max of 15 days)."
            }, 
            {
                "measure": "Fibrinogen (g / l)", 
                "safety_issue": "No", 
                "time_frame": "Upon diagnosis (day 0)"
            }, 
            {
                "measure": "Fibrinogen (g / l)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Fibrinogen (g / l)", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }, 
            {
                "measure": "Hematocrit (%)", 
                "safety_issue": "No", 
                "time_frame": "Upon diagnosis (day 0)"
            }, 
            {
                "measure": "Hematocrit (%)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Hematocrit (%)", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }, 
            {
                "measure": "Hematocrit (%)", 
                "safety_issue": "No", 
                "time_frame": "the month preceding delivery"
            }, 
            {
                "measure": "Hemoglobin (g/dl)", 
                "safety_issue": "No", 
                "time_frame": "Upon diagnosis (day 0)"
            }, 
            {
                "measure": "Hemoglobin (g/dl)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Hemoglobin (g/dl)", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }, 
            {
                "measure": "Hemoglobin (g/dl)", 
                "safety_issue": "No", 
                "time_frame": "the month preceding delivery"
            }, 
            {
                "measure": "Prothrombin (%)", 
                "safety_issue": "No", 
                "time_frame": "the month preceding delivery"
            }, 
            {
                "measure": "Prothrombin (%)", 
                "safety_issue": "No", 
                "time_frame": "Upon diagnosis (day 0)"
            }, 
            {
                "measure": "Prothrombin (%)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Prothrombin (%)", 
                "safety_issue": "No", 
                "time_frame": "Day 3"
            }, 
            {
                "measure": "Activated partial thromboplastin time (s)", 
                "safety_issue": "No", 
                "time_frame": "the month preceding delivery"
            }, 
            {
                "measure": "Activated partial thromboplastin time (s)", 
                "safety_issue": "No", 
                "time_frame": "Upon diagnosis (day 0)"
            }, 
            {
                "measure": "Activated partial thromboplastin time (s)", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "Activated partial thromboplastin time (s)", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "measure": "Length of hospital stay (days)", 
                "safety_issue": "No", 
                "time_frame": "Expected max of 15 days"
            }, 
            {
                "measure": "Length of ICU stay", 
                "safety_issue": "No", 
                "time_frame": "expected max of 15 days"
            }, 
            {
                "measure": "Antimullerian hormone level", 
                "safety_issue": "No", 
                "time_frame": "Upon diagnosis (Day 0)"
            }, 
            {
                "measure": "Antimullerian hormone level", 
                "safety_issue": "No", 
                "time_frame": "2 months after restart of menses"
            }, 
            {
                "description": "(Excluding breastfeeding women)", 
                "measure": "Amenorrhea at 3 months?  yes/no", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "The presence of adhesions detected at hysteroscopy", 
                "safety_issue": "No", 
                "time_frame": "3 months after delivery if menses have restarted, or 2 months after the restart of menses (maximum of 1 year after inclusion)"
            }, 
            {
                "measure": "pain will be assessed in both arms via a visual analog scale, duration, location, and use of analgesics", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1"
            }, 
            {
                "measure": "pain will be assessed in both arms via a visual analog scale, duration, location, and use of analgesics", 
                "safety_issue": "Yes", 
                "time_frame": "Day 3"
            }, 
            {
                "measure": "temperature (\u00b0C)", 
                "safety_issue": "Yes", 
                "time_frame": "Daily while in hospital (expected maximum of 15 days)"
            }, 
            {
                "measure": "FSFI questionnaire (Female Sexual Function Index)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Doppler ultrasound: intra-uterine pressure", 
                "safety_issue": "No", 
                "time_frame": "when placing the Bakri baloon; day 0"
            }, 
            {
                "measure": "Doppler ultrasound: thickness of the uterine wall", 
                "safety_issue": "No", 
                "time_frame": "when placing the Bakri baloon; day 0"
            }, 
            {
                "measure": "Doppler ultrasound: inversed diastolic flow", 
                "safety_issue": "No", 
                "time_frame": "when placing the Bakri baloon; day 0"
            }, 
            {
                "measure": "Doppler ultrasound: intraluminal pressure", 
                "safety_issue": "No", 
                "time_frame": "when placing the Bakri baloon; day 0"
            }, 
            {
                "measure": "Doppler ultrasound: uterine artery perfusion pressure", 
                "safety_issue": "No", 
                "time_frame": "when placing the Bakri baloon; day 0"
            }, 
            {
                "measure": "Doppler ultrasound: uterine artery pulsatility index", 
                "safety_issue": "No", 
                "time_frame": "when placing the Bakri baloon; day 0"
            }, 
            {
                "measure": "IES-R scale (symptoms of post-traumatic stress)", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de N\u012bmes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de N\u012bmes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}